These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Water Networks and Correlated Motions in Mutant Isocitrate Dehydrogenase 1 (IDH1) Are Critical for Allosteric Inhibitor Binding and Activity. Chambers JM; Miller W; Quichocho G; Upadhye V; Matteo DA; Bobkov AA; Sohl CD; Schiffer JM Biochemistry; 2020 Feb; 59(4):479-490. PubMed ID: 31869219 [TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of "off-on switch" of activities of human IDH1 by tumor-associated mutation R132H. Yang B; Zhong C; Peng Y; Lai Z; Ding J Cell Res; 2010 Nov; 20(11):1188-200. PubMed ID: 20975740 [TBL] [Abstract][Full Text] [Related]
10. Isocitrate dehydrogenase mutations in gliomas. Waitkus MS; Diplas BH; Yan H Neuro Oncol; 2016 Jan; 18(1):16-26. PubMed ID: 26188014 [TBL] [Abstract][Full Text] [Related]
11. Inhibitor potency varies widely among tumor-relevant human isocitrate dehydrogenase 1 mutants. Avellaneda Matteo D; Wells GA; Luna LA; Grunseth AJ; Zagnitko O; Scott DA; Hoang A; Luthra A; Swairjo MA; Schiffer JM; Sohl CD Biochem J; 2018 Oct; 475(20):3221-3238. PubMed ID: 30249606 [TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and hydrophobicity at residue 132 on catalytic efficiency. Avellaneda Matteo D; Grunseth AJ; Gonzalez ER; Anselmo SL; Kennedy MA; Moman P; Scott DA; Hoang A; Sohl CD J Biol Chem; 2017 May; 292(19):7971-7983. PubMed ID: 28330869 [TBL] [Abstract][Full Text] [Related]
13. Identification and Characterization of Small-Molecule Inhibitors of the R132H/R132H Mutant Isocitrate Dehydrogenase 1 Homodimer and R132H/Wild-Type Heterodimer. Brooks E; Wu X; Hanel A; Nguyen S; Wang J; Zhang JH; Harrison A; Zhang W J Biomol Screen; 2014 Sep; 19(8):1193-200. PubMed ID: 24980596 [TBL] [Abstract][Full Text] [Related]
14. Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells. Li L; Paz AC; Wilky BA; Johnson B; Galoian K; Rosenberg A; Hu G; Tinoco G; Bodamer O; Trent JC PLoS One; 2015; 10(9):e0133813. PubMed ID: 26368816 [TBL] [Abstract][Full Text] [Related]
15. Identification of a novel inactivating mutation in Isocitrate Dehydrogenase 1 (IDH1-R314C) in a high grade astrocytoma. van Lith SA; Navis AC; Lenting K; Verrijp K; Schepens JT; Hendriks WJ; Schubert NA; Venselaar H; Wevers RA; van Rooij A; Wesseling P; Molenaar RJ; van Noorden CJ; Pusch S; Tops B; Leenders WP Sci Rep; 2016 Jul; 6():30486. PubMed ID: 27460417 [TBL] [Abstract][Full Text] [Related]